TACITURNITY

TACITURNITY was reported 88 times

These drug classes are most commonly taken by patients reporting TACITURNITY:

# Drug Count
0 Atypical Antipsychotic [EPC] 19
1 Interferon beta [EPC] 10
2 Nonsteroidal Anti-inflammatory Drug [EPC] 8
3 Integrin Receptor Antagonist [EPC] 7
4 Benzodiazepine [EPC] 4
5 Mood Stabilizer [EPC] 3
6 Platelet Aggregation Inhibitor [EPC] 3
7 Aldosterone Antagonist [EPC] 2
8 Anti-epileptic Agent [EPC] 2
9 Aromatic Amino Acid [EPC] 2
10 Catechol-O-Methyltransferase Inhibitor [EPC] 2
11 Central alpha-2 Adrenergic Agonist [EPC] 2
12 Dihydropyridine Calcium Channel Blocker [EPC] 2
13 Expectorant [EPC] 2
14 Factor Xa Inhibitor [EPC] 2
15 HMG-CoA Reductase Inhibitor [EPC] 2
16 Kinase Inhibitor [EPC] 2
17 Nucleoside Metabolic Inhibitor [EPC] 2
18 Orexin Receptor Antagonist [EPC] 2
19 Platinum-based Drug [EPC] 2
20 Proton Pump Inhibitor [EPC] 2
21 Sulfonylurea [EPC] 2
22 Thiazide-like Diuretic [EPC] 2
23 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2
24 Alkylating Drug [EPC] 1
25 Angiotensin 2 Receptor Blocker [EPC] 1
26 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1
27 Barbiturate [EPC] 1
28 Calcium Channel Blocker [EPC] 1
29 Central Nervous System Stimulant [EPC] 1
30 Cholinesterase Inhibitor [EPC] 1
31 Corticosteroid [EPC] 1
32 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
33 Insulin Analog [EPC] 1
34 Insulin [EPC] 1
35 Loop Diuretic [EPC] 1
36 Methylxanthine [EPC] 1
37 Monoamine Oxidase Inhibitor [EPC] 1
38 Monoamine Oxidase Type B Inhibitor [EPC] 1
39 Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] 1
40 Osmotic Laxative [EPC] 1
41 Phosphodiesterase 4 Inhibitor [EPC] 1
42 Potassium-sparing Diuretic [EPC] 1
43 Provitamin D2 Compound [EPC] 1
44 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
45 Stimulant Laxative [EPC] 1
46 Typical Antipsychotic [EPC] 1
47 Xanthine Oxidase Inhibitor [EPC] 1
48 alpha-Adrenergic Blocker [EPC] 1
49 beta3-Adrenergic Agonist [EPC] 1